Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brazil strengthens research and development in cardiac cell therapy

This article was originally published in Clinica

Executive Summary

Brazil's National Cardiology Institute at Laranjeiras (INCL), in Rio de Janeiro city, has inaugurated a refurbished blood collection and haematology centre, which will serve to support what it is describing as the world's largest cardiopathy stem cell therapy study. The INCL, which conducted around 1,230 such procedures in 2005, receives 280-350 blood donations per month to support its surgery programme.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT052560

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel